Thursday, September 03, 2020 1:15:03 PM
Not sure how the company can be sold without considering due interest of all shareholders, not only for the 64%. Beyond me.
Besides, have the board been replaced as of yet? GEM controls only 30.93% of the registered shares. The rest is call option/warrants exercised period 2022/2023 for most part.
Many things can happen, but they have not happened.
$RLFT
imho only
Besides, have the board been replaced as of yet? GEM controls only 30.93% of the registered shares. The rest is call option/warrants exercised period 2022/2023 for most part.
Many things can happen, but they have not happened.
$RLFT
imho only
Recent RLFTF News
- MindMaze Therapeutics Announces Initiation of Coverage by Baader Bank • ACCESS Newswire • 03/19/2026 06:35:00 AM
- MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics • ACCESS Newswire • 12/23/2025 06:20:00 AM
- Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics • ACCESS Newswire • 12/15/2025 06:20:00 AM
- Relief Therapeutics Shareholders Approve Business Combination with NeuroX • ACCESS Newswire • 11/14/2025 05:40:00 PM
- Relief Therapeutics Announces Positive Results from Pivotal Bioequivalence Study of RLF-OD032 • ACCESS Newswire • 10/29/2025 06:20:00 AM
